Global Cell Surface Markers Market 2024-2028

Global Cell Surface Markers Market 2024-2028

The cell surface markers market is forecasted to grow by USD 14068.95 mn during 2023-2028, accelerating at a CAGR of 8.25% during the forecast period. The report on the cell surface markers market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by COVID-19 pandemic impact, increasing demand for precision medicine, and increasing use of diagnostics.

Technavio's cell surface markers market is segmented as below:

By Application

• Disease diagnosis
• Research
• drug discovery

By Product

• Antibody
• PCR array

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the increased use of diagnostics in cancer detection as one of the prime reasons driving the cell surface markers market growth during the next few years. Also, increasing popularity of flow cytometry technique and integration of artificial intelligence and machine learning will lead to sizable demand in the market.

The report on the cell surface markers market covers the following areas:

• Cell surface markers market sizing
• Cell surface markers market forecast
• Cell surface markers market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading cell surface markers market vendors that include Abbott Laboratories, Abcam plc, Agilent Technologies Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., Bio Techne Corp., Cell Signaling Technology Inc., Danaher Corp., DiaSorin SpA, F. Hoffmann La Roche Ltd., GenScript Biotech Corp., Grifols SA, IVD Medical Holding Ltd., Johnson and Johnson, PerkinElmer Inc., QIAGEN NV, Siemens Healthineers AG, Sysmex Corp., Thermo Fisher Scientific Inc., and Werfenlife SA. Also, the cell surface markers market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth